CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 4 Open-market sale Chief Financial Officer sold 3,437 shares at $12.80 ($43,994)
- 4 Open-market sale Chief Medical Officer sold 1,563 shares at $12.80 ($20,006)
- 4 Open-market sale President and CEO sold 2,732 shares at $12.80 ($34,970)
- 4 Open-market sale President and CEO sold 97,268 shares at $13.42 ($1,305,337)
- 4 Grant or award Chief Financial Officer acquired 80,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 80,000 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 419 shares at $12.92 ($5,413)
- 4 Open-market sale Chief Financial Officer sold 4,184 shares at $12.92 ($54,057)
- 4 Open-market sale President and CEO sold 100,000 shares at $13.65 ($1,365,000)
- 4 Open-market sale President and CEO sold 2,348 shares at $17.04 ($40,010)
- 4 Open-market sale Chief Financial Officer sold 1,253 shares at $17.04 ($21,351)
- 4 Open-market sale Chief Medical Officer sold 1,253 shares at $17.04 ($21,351)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 100,000 shares at $19.33 ($1,933,000)
- 4 Open-market sale Chief Financial Officer sold 3,152 shares at $21.25 ($66,980)
- 4 Open-market sale Chief Scientific Officer sold 1,088 shares at $21.25 ($23,120)
Page 19 of 28 · 557 filings